Showing results (11-20 of 162) with videos related to

Sort By:
Pageof 17
Cancer Research|March 17, 2006
Vascular proliferation is important for clinical progress of endometrial cancerIngunn M Stefansson, Helga B Salvesen, Lars A Akslen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
Prognostic impact of alterations in P-cadherin expression and related cell adhesion markers in endometrial cancerIngunn M Stefansson, Helga B Salvesen, Lars A Akslen
International Journal of Cancer|September 10, 2005
Loss of p63 and cytokeratin 5/6 expression is associated with more aggressive tumors in endometrial carcinoma patientsIngunn M Stefansson, Helga B Salvesen, Lars A Akslen
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 11, 2009
Parity and time interval since childbirth influence survival in endometrial cancer patientsGrethe Albrektsen, Ivar Heuch, Elisabeth Wik, et al.
Histopathology|February 12, 2009
Importance of tumour cell invasion in blood and lymphatic vasculature among patients with endometrial carcinomaMonica Mannelqvist, Ingunn Stefansson, Helga B Salvesen, et al.
Acta Obstetricia Et Gynecologica Scandinavica|March 9, 2011
Follow-up routines in gynecological cancer - time for a change?Ingvild Vistad, Birgit W Moy, Helga B Salvesen, et al.
American Journal of Obstetrics and Gynecology|May 9, 2006
Pathologic expression of p53 or p16 in preoperative curettage specimens identifies high-risk endometrial carcinomasIngeborg B Engelsen, Ingunn Stefansson, Lars A Akslen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|November 25, 2003
Significance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomasHelga B Salvesen, Mine G Gulluoglu, Ingunn Stefansson, et al.
Pathology, Research and Practice|August 16, 2014
Molecular profiling in fresh tissue with high tumor cell content promotes enrichment for aggressive adenocarcinomas in cervixMari Kyllesø Halle, Camilla Krakstad, Hilde Engerud, et al.
American Journal of Obstetrics and Gynecology|July 5, 2008
GATA3 expression in estrogen receptor alpha-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survivalIngeborg B Engelsen, Ingunn M Stefansson, Lars A Akslen, et al.
Pageof 17